Literature DB >> 19475674

Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.

Renee G Stark1, Peter Reitmeir, Reiner Leidl, Hans-Helmut König.   

Abstract

BACKGROUND: The EuroQol (EQ)-5D questionnaire is a generic instrument measuring health-related quality of life. Its validity, reliability, and responsiveness were assessed in a large sample of Crohn's disease (CD) and ulcerative colitis (UC) patients.
METHODS: The EQ-5D was completed initially (270 CD and 232 UC subjects) and after 4 weeks (447 subjects) with a transition question rating health change. Responsiveness of EQ visual analog scale (EQ-VAS) and the United Kingdom (UK-index) and German EQ-5D index (EQ-index) scores to reported changes in health was evaluated by standardized response means (SRM) and meaningful differences (MDs).
RESULTS: EQ-VAS and EQ-index scores correlated well with disease activity indices and differed significantly between active disease and remission groups. All scores were reliable in test-retest (ICC: EQ-VAS: 0.89; UK-index: 0.76; German EQ-index: 0.72). According to SRM, EQ-VAS was more responsive for deterioration in health than for improvement in health and was more responsive than index scores. Index scores were most responsive for deterioration in health in subjects in remission and for improved health in subjects with active disease. MDs for improved health (EQ-VAS: 10.9; UK EQ-index: 0.076; German EQ-index: 0.050) and deteriorated health (EQ-VAS: -14.4; UK EQ-index: -0.109; German EQ-index: -0.067) were significant, but MD of EQ-VAS also differed significantly according to disease activity.
CONCLUSIONS: The EQ-5D generates valid, reliable, and responsive preference-based evaluations of health in CD and UC. EQ-VAS scores were more responsive than EQ-5D index scores. Thus, small health differences that are important from the patient's perspective may not be reflected in the EQ-index.

Entities:  

Mesh:

Year:  2010        PMID: 19475674     DOI: 10.1002/ibd.20989

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  32 in total

1.  Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.

Authors:  Steven J Edwards; Samantha Barton; Mariana Bacelar; Charlotta Karner; Peter Cain; Victoria Wakefield; Gemma Marceniuk
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

2.  A value set for the EQ-5D based on experienced health states: development and testing for the German population.

Authors:  Reiner Leidl; Peter Reitmeir
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

Review 3.  Can The EQ-5D Detect Meaningful Change? A Systematic Review.

Authors:  Nalin Payakachat; Mir M Ali; J Mick Tilford
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

4.  Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied?

Authors:  Klazien Matter-Walstra; Dirk Klingbiel; Thomas Szucs; Bernhard C Pestalozzi; Matthias Schwenkglenks
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

Review 5.  EQ-5D in Central and Eastern Europe: 2000-2015.

Authors:  Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek
Journal:  Qual Life Res       Date:  2016-07-29       Impact factor: 4.147

6.  Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational study.

Authors:  Carolynne J Vaizey; Peter R Gibson; Christopher M Black; Rebecca J Nicholls; Adèle R Weston; Daniel R Gaya; Shaji Sebastian; Ian Shaw; Stephen Lewis; Stuart Bloom; John N Gordon; Amanda Beale; Ian Arnott; Simon Campbell; Tao Fan
Journal:  Frontline Gastroenterol       Date:  2014-01-24

7.  The German PASS-20 in patients with low back pain: new aspects of convergent, divergent, and criterion-related validity.

Authors:  Nina Kreddig; Adina C Rusu; Katja Burkhardt; Monika I Hasenbring
Journal:  Int J Behav Med       Date:  2015-04

8.  DEEP Study: does EQ-5D-5L measure the impacts of persistent oro-facial pain?

Authors:  J Durham; J G Steele; M Breckons; W Story; L Vale
Journal:  J Oral Rehabil       Date:  2015-03-30       Impact factor: 3.837

9.  The discriminative power of the EuroQol visual analog scale is sensitive to survey language in Singapore.

Authors:  Nan Luo; Sheng-Qun Cang; Hui-Min Joanne Quah; Choon-How How; Ee Guan Tay
Journal:  Health Qual Life Outcomes       Date:  2012-03-20       Impact factor: 3.186

10.  Long-term effectiveness and outcome predictors of therapist-guided internet-based cognitive-behavioural therapy for social anxiety disorder in routine psychiatric care.

Authors:  Samir El Alaoui; Erik Hedman; Brjánn Ljótsson; Nils Lindefors
Journal:  BMJ Open       Date:  2015-06-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.